Tech support
Shopping Cart
Login
Register
Forgot Password?
Products
Diagnostics
Suppliers
About us
Contact
+31 (0)26 326 4450
Find the product you need
Description
Catalog number
CAS No.
Clone ID
News
Vorige
Volgende
InVivoMab anti-mouse PD-L1 (B7-H1)
Catalog number:
BE0101_100mg
Brand:
Bio X Cell
Packing:
100 mg
Other sizes:
Other sizes available
Price:
€ 3257.00
Expected delivery time:
7 days
Quantity:
Spin Up
Spin Down
General
References
Product specifications for - InVivoMab anti-mouse PD-L1 (B7-H1)
Promotion:
Promotion:
The price displayed is only for academic or non-profit organizations. Please
contact our helpdesk
for regular prices.
Overview:
Product group:
Antibodies
Category:
Primary Antibodies
Application:
Flow Cytometry; ImmunoFluorescence; ImmunoHistoChemistry; ImmunoHistoChemistry Frozen; Neutralisation/Blocking
Host:
Rat
Clonality:
Monoclonal
Isotype:
IgG2b Kappa
Properties:
Molecular weight:
150 kDa
Datasheet:
Datasheet
Research Use Only
UNSPSC:
12352203
Concentration:
2-10 mg/ml
Scientific information:
Clone ID:
10F.9G2
Related products:
Related products:
Recommended Isotype Control(s):
InVivoMab rat IgG2b isotype control (BE0090)
Recommended Dilution Buffer:
InVivoPure pH 6.5 Dilution Buffer (IP0065)
Additional information:
Synonyms:
10F.9G2; BE0101; B7-H1 / PD-L1 / CD274; CD274; PDL1; PDCD1LG1; PDCD1L1; PD-L1; B7H1; B7-H; programmed death ligand 1; programmed cell death 1 ligand 1; PDCD1 ligand 1; CD274 antigen; B7 homolog 1; CD274 molecule; BioXCell
Ngiow SF, Young A, Jacquelot N, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75(18):3800-11.
Read more
Tkachev V, Goodell S, Opipari AW, et al. Programmed death-1 controls T cell survival by regulating oxidative metabolism. J Immunol. 2015;194(12):5789-800.
Read more
Zander RA, Obeng-adjei N, Guthmiller JJ, et al. PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity. Cell Host Microbe. 2015;17(5):628-41.
Read more
Twyman-saint victor C, Rech AJ, Maity A, et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature. 2015;520(7547):373-7.
Read more
Jaworska K, Ratajczak J, Huang L, et al. Both PD-1 ligands protect the kidney from ischemia reperfusion injury. J Immunol. 2015;194(1):325-33.
Read more
Dolina JS, Braciale TJ, Hahn YS. Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice. Hepatology. 2014;59(4):1351-65.
Read more
Yang X, Zhang X, Fu ML, et al. Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses. Cancer Cell. 2014;25(1):37-48.
Read more
Deng L, Liang H, Burnette B, et al. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest. 2014;124(2):687-95.
Read more
Dietze KK, Zelinskyy G, Liu J, Kretzmer F, Schimmer S, Dittmer U. Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads. PLoS Pathog. 2013;9(12):e1003798.
Read more
Rutigliano JA, Sharma S, Morris MY, et al. Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells. J Virol. 2014;88(3):1636-51.
Read more
See All